本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jasper Therapeutics

2.28
+0.10004.59%
盤後2.27-0.0100-0.44%19:12 EDT
成交量:24.17萬
成交額:54.64萬
市值:6,366.68萬
市盈率:-0.38
高:2.33
開:2.22
低:2.20
收:2.18
52周最高:26.05
52周最低:2.16
股本:2,792.40萬
流通股本:2,281.03萬
量比:0.51
換手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-6.0237
每股收益(LYR):-4.8865
淨資產收益率:-146.87%
總資產收益率:-73.30%
市淨率:2.71
市盈率(LYR):-0.47

資料載入中...

2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]